Endo International plc – Ordinary Shares


Endo International plc – Ordinary Shares (ENDP) Wins FDA Approval of Ephedrine Sulfate Injection, USP

Endo International plc (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S.

Stock Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Announces Appointment of Blaise Coleman as Chief Financial Officer

Endo International plc – Ordinary Shares (NASDAQ: ENDP) announced that it has appointed Blaise Coleman as Executive Vice President and Chief Financial Officer, …

Stock Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Starts Shipment of Generic ZETIA

Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping ezetimibe 10 mg tablets, …

Company Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Announces Strategic Updates for BELBUCA and U.S. Branded Pain Portfolio

Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that it has entered into an agreement with its partner, BioDelivery Sciences International, Inc. (BDSI), to return …

Stock Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Begins Shipment of Generic CellCept

Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping mycophenolate mofetil hydrochloride (HCl) …

JMP Encouraged on Endo International plc – Ordinary Shares (ENDP) Following Statistically Significant Phase 2B Cellulite Data Results

JMP analyst Donald Ellis is encouraged on Endo International plc – Ordinary Shares (NASDAQ:ENDP) after the biotech firm’s pipeline drug Xiaflex, used to …

Company Update (NASDAQ:ENDP): Endo International plc Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced today positive results from its Phase 2b study of collagenase clostridium histolyticum (or “CCH”) for …

Biotech Talk: Valeant Pharmaceuticals Intl Inc (VRX) and Endo International (ENDP)

Amid President Elect Donald Trump’s victory, stocks in the biotech sector are on an upturn now that the Clinton Administration will not be …

Endo International plc – Ordinary Shares (ENDP) Announces 3Q:16 Financial Results; Shares Fall 6%

Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported third quarter 2016 financial results, including: Revenues of $884 million including the addition of sales …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts